1. Surgical treatment of atrial fibrillation using cryoablation

Авторы

DOI:

https://doi.org/10.35805/BSK2024IV001

Загрузки

Аннотация

Background. This study presents the results of a clinical trial evaluating the effectiveness of surgical treatments for atrial fibrillation in patients with rheumatic mitral valve disease. Special attention is given to the comparison of cryoablation and radiofrequency ablation, two methods used in conjunction with mitral valve surgeries. The results indicate that cryoablation, a method first used in Kazakhstan, has long-term advantages for restoring sinus rhythm and cardiac remodeling, thereby improving patients' quality of life. Materials and

Methods. The study was conducted at the period from January 2020 to March 2024 through a retrospective analysis of data from patients with atrial fibrillation and rheumatic mitral valve disease who underwent surgical treatment using one of two methods: Cryoablation with left atrial appendage clipping (Group I) – 50 patients; Radiofrequency ablation with left atrial appendage suturing (Group II) – 50 patients.

Results. According to the conducted research, both cryoablation and radiofrequency ablation are highly effective in restoring sinus rhythm in patients with atrial fibrillation and rheumatic mitral valve disease. Cryoablation, a procedure that was used for the first time in Kazakhstan, demonstrated significant advantages in the long-term maintenance of sinus rhythm and improvement in heart remodeling parameters, such as left atrial volume. This has enhanced the quality of life for patients. Conclusions. There is a need for the widespread implementation of innovative treatments for atrial fibrillation, such as cryoablation, as surgical procedures are more effective and patients with severe cardiovascular diseases have better outcomes.

Ключевые слова

Atrial fibrillation, cryoablation, radiofrequency ablation, rheumatic mitral valve disease, sinus rhythm, surgical treatment of arrhythmias

Библиографические ссылки

  1. Lippi G, Sanchis-Gomar F, Cervel-lin G. Global epidemiology of atrial fibrillation: An increasing epidem-ic and public health challenge. Int J Stroke. Feb 2021;16(2):217-221. doi:10.1177/1747493019897870
  2. Bai Y, Wang YL, Shantsila A, Lip GYH. The Global Burden of Atrial Fibril-lation and Stroke: A Systematic Re-view of the Clinical Epidemiology of Atrial Fibrillation in Asia. Chest. Oct 2017;152(4):810-820. doi:10.1016/j.chest.2017.03.048
  3. Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. Jul 14 2016;13(8):501. doi:10.1038/nrcar-dio.2016.114
  4. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atri-al fibrillation developed in collab-oration with the European Associ-ation for Cardio-Thoracic Surgery (EACTS): The Task Force for the di-agnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the Eu-ropean Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. Feb 1 2021;42(5):373-498. doi:10.1093/eurheartj/ehaa612
  5. Baimbetov AK, Bizhanov KA, Ab-zaliyev KB, Bairamov BA, Yakupova IA. Prediction of arrhythmia recur-rence after atrial fibrillation abla-tion in patients with normal anatomy of the left atrium. Int J Clin Pract. Jun 2021;75(6):e14083. doi:10.1111/ijcp.14083
  6. Bizhanov KA, capital A CKB, Baim-betov AK, Sarsenbayeva AB, Lyan E. Atrial fibrillation: Epidemiolo-gy, pathophysiology, and clinical complications (literature review). J Cardiovasc Electrophysiol. Jan 2023;34(1):153-165. doi:10.1111/jce.15759
  7. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvu-lar Heart Disease: executive sum-mary: a report of the American Col-lege of Cardiology/American Heart Association Task Force on Prac-tice Guidelines. Circulation. Jun 10 2014;129(23):2440-92. doi:10.1161/CIR.0000000000000029
  8. Baimbetov AK, Abzaliev KB, Jukeno-va AM, Bizhanov KA, Bairamov BA, Ualiyeva AY. Retraction Note: The ef-ficacy and safety of cryoballoon cath-eter ablation in patients with parox-ysmal atrial fibrillation. Ir J Med Sci. Feb 2024;193(1):539. doi:10.1007/s11845-023-03458-8
  9. Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statis-tics-2021 Update: A Report From the American Heart Association. Circu-lation. Feb 23 2021;143(8):e254-e743. doi:10.1161/CIR.0000000000000950
  10. Chun KRJ, Perrotta L, Bordignon S, et al. Complications in Catheter Ab-lation of Atrial Fibrillation in 3,000 Consecutive Procedures: Balloon Versus Radiofrequency Current Ab-lation. JACC Clin Electrophysiol. Feb 2017;3(2):154-161. doi:10.1016/j.ja-cep.2016.07.002
  11. Andrade JG, Khairy P, Macle L, et al. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treat-ment of Paroxysmal Atrial Fibrilla-tion (STOP AF) Trial. Circ Arrhythm Electrophysiol. Feb 2014;7(1):69-75. doi:10.1161/CIRCEP.113.000586
  12. Baimbetov AK, Abzaliev KB, Jukeno-va AM, Bizhanov KA, Bairamov BA, Ualiyeva AY. The efficacy and safety of cryoballoon catheter ab-lation in patients with paroxysmal atrial fibrillation. Ir J Med Sci. Feb 2022;191(1):187-193. doi:10.1007/s11845-021-02560-ztinuoussupportwereessentialforthesuccessfulcompletionofthiswork.Author’scontributions.N.Zh.,T.R.:Studyconcept;N.Zh.,D.A.:Studyde-sign;N.Zh,Y.D.:Dataanalysis;N.Zh,T.R.:Draftingofmanuscript;N.Zh,T.R.,D.A.:
  13. Chen X, Xia Y, Lin Y, et al. Cryob-alloon Ablation for Treatment of Atrial Fibrillation in a Chinese Pop-ulation: Five-Year Outcomes and Predictors of Recurrence After a Single Procedure. Front Cardiovasc Med. 2022;9:836392. doi:10.3389/fcvm.2022.836392
  14. Schmidt M, Dorwarth U, Andresen D, et al. German ablation registry: Cryoballoon vs. radiofrequency ab-lation in paroxysmal atrial fibrilla-tion--One-year outcome data. Heart Rhythm. Apr 2016;13(4):836-44. doi:10.1016/j.hrthm.2015.12.007
  15. Tomaiko E, Su WW. Comparing radiofrequency and cryoballoon technology for the ablation of atri-al fibrillation. Curr Opin Cardiol. Jan 2019;34(1):1-5. doi:10.1097/HCO.0000000000000578
  16. Engin M, Gursoy NC, Tatli AB. Im-portance of additional risk factors in postoperative atrial fibrillation risk analysis methods. Rev Assoc Med Bras (1992). 2024;70(2):e20231319. doi:10.1590/1806-9282.20231319
  17. Kuck KH, Furnkranz A, Chun KR, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxys-mal atrial fibrillation: reinterven-tion, rehospitalization, and qual-ity-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. Oct 7 2016;37(38):2858-2865. doi:10.1093/eurheartj/ehw285
  18. Andrade JG, Champagne J, Dubuc M, et al. Cryoballoon or Radiofre-quency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. Circu-lation. Nov 26 2019;140(22):1779-1788. doi:10.1161/CIRCULATIONA-HA.119.042622
  19. Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or Radiofrequen-cy Ablation for Paroxysmal Atri-al Fibrillation. N Engl J Med. Jun 9 2016;374(23):2235-45. doi:10.1056/NEJMoa1602014

Опубликован

2024-12-31

Выпуск

№ 4 (2024)

Раздел

Статьи